A critical advance in cancer research is occurring with the use of nanobodies to reactivate damaged p53. This vital malignant inhibitor protein is frequently inactivated in many kinds of malignancies, causing https://thebookmarkid.com/story22063493/mini-antibodies-revive-p53-the-promising-pathway-for-tumor-management